NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and General Counsel James Basta sold $76K of Intellia Therapeutics, Inc.
Sold$75,778
$32.99Price
2,297Shares
−3%Stake
What NTLA did after the filing
- The stock from Tue, Mar 5 close, $30.25
- −28.9%
- S&P 500, same days
- −1.0%
Measured over 30 trading days, to the Apr 17 close.
Traded Mon, Mar 4. Filed Tue, Mar 5, 11:10 AM ET, during the session. Returns use the Mar 5 close and the Apr 17 close. Not investment advice.